热门资讯> 正文
NuCana任命Theresa Bruce为首席运营官
2026-01-06 22:08
- NuCana (NCNA) announced on Tuesday the appointment of Theresa Bruce as chief operating officer, effective January 1, 2026.
- Bruce previously served as chief operating officer at Nexus Oncology and has held senior leadership roles at both clinical research organizations and biotechnology companies, including senior vice president of clinical operations at Chiltern and Veristat. Most recently, Bruce served as Senior Vice President of Clinical Operations at NuCana. Before joining NuCana, she also worked as an independent consultant to U.S.-based biotechnology companies.
- NCNA -1.24% premarket to $3.654.
- Source: Press Release
More on NuCana
- NuCana GAAP EPS of £0.00
- Seeking Alpha’s Quant Rating on NuCana
- Financial information for NuCana
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。